Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-235229
Filing Date
2024-10-09
Accepted
2024-10-09 16:16:03
Documents
9
Effectiveness Date
2024-10-09

Document Format Files

Seq Description Document Type Size
1 S-3ASR d842973ds3asr.htm S-3ASR 409097
2 EX-4.2 d842973dex42.htm EX-4.2 31624
3 EX-4.3 d842973dex43.htm EX-4.3 249939
4 EX-5.1 d842973dex51.htm EX-5.1 27408
5 EX-23.1 d842973dex231.htm EX-23.1 1296
6 EX-FILING FEES d842973dexfilingfees.htm EX-FILING FEES 44837
7 GRAPHIC g842973g01a01.jpg GRAPHIC 67283
8 GRAPHIC g842973g01a02.jpg GRAPHIC 58980
9 GRAPHIC g842973g0519232110257.jpg GRAPHIC 4291
  Complete submission text file 0001193125-24-235229.txt   945638
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-282561 | Film No.: 241362955
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)